Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4185086 | 0.88 | MEN1 (0.43) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL136476 | 0.69 | ALDH1A1 (0.67) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL31300122 | 0.69 | AKR1C3 (0.40) | MEN1KMT2AGAAMGLLMMP13 | |
| SCHEMBL5666187 | 0.69 | ALDH1A1 (0.41) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL23841260 | 0.69 | KMT2A (0.65) | ALDH1A1MEN1KMT2ALMNAHPGD | |
| SCHEMBL718072 | 0.69 | KMT2A (0.63) | ALDH1A1MEN1KMT2ALMNAHPGD | |
| SCHEMBL76559 | 0.68 | ALDH1A1 (0.59) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| Hydrochloric Acid SCHEMBL7466356 | 0.68 | ALDH1A1 (0.65) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL27409503 | 0.68 | ALDH1A1 (0.59) | ALDH1A1CYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL849461 | 0.68 | L3MBTL1 (0.57) | ALDH1A1MEN1KMT2AL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1317013-B1 | NON-AQUEOUS ELECTROLYTE AND SECONDARY CELL USING THE SAME | MITSUBISHI CHEM CORP (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-7186844-B2 | Method for producing cyclic carbamate ester | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-6942948-B2 | Nonaqueous electrolyte solution and secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-09-13 | — | — | US | disclosed |
| US-20050154200-A1 | Method for producing cyclic carbamate ester | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-07-14 | — | — | US | disclosed |
| US-20030165733-A1 | Nonaqueous electrolyte solution and secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-09-04 | — | — | US | disclosed |
| EP-1317013-A1 | NON-AQUEOUS ELECTROLYTE AND SECONDARY CELL USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154200-A1 | Method for producing cyclic carbamate ester | CPS1, BCHE, CES2 | ALDH1A1 3167/4885CYP1A2 642/4885CYP2C9 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.